Literature DB >> 21076929

Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes.

I Vickers1, D O'Flanagan, M Cafferkey, H Humphreys.   

Abstract

The purpose of this study was to determine the serotypes, genotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing otitis media (OM) in children in Dublin, Ireland. S. pneumoniae isolates (n = 28) from spontaneously discharging OM were studied. Serotyping was performed using a previously undescribed multiplex polymerase chain reaction (PCR) scheme in combination with serological methods. Multilocus sequence typing (MLST) was performed using standard procedures. Antimicrobial susceptibility testing was performed using the Etest method. Fourteen different S. pneumoniae serotypes were identified. The five most common serotypes were 3, 19F, 19A, 14 and 6A, which accounted for 68% of all infections. The 7-valent pneumococcal conjugate vaccine (PCV7), 10-valent pneumococcal conjugate vaccine (PHiD-CV) and 13-valent pneumococcal conjugate vaccine (PCV13) provided potential coverages of 43%, 46% and 86%, respectively. Reduced susceptibility to penicillin was evident for 25% of isolates and was associated with serotypes 14, 19A, 19F and 9V. A total of 21 different sequence types (STs) were identified. Pneumococcal Molecular Epidemiology Network (PMEN) clones or their variants represented 54% (15/28) of all isolates. Continued monitoring and characterisation of S. pneumoniae causing OM in Ireland is warranted in order to guide future vaccine and treatment policies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076929     DOI: 10.1007/s10096-010-1108-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989.

Authors:  A Fenoll; C Martín Bourgon; R Muñóz; D Vicioso; J Casal
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine.

Authors:  Damien M O'halloran; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Molecular analysis by pulsed-field gel electrophoresis of penicillin-resistant Streptococcus pneumoniae from Toulouse, France.

Authors:  J C Lefèvre; M A Bertrand; G Faucon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

4.  Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain.

Authors:  F del Castillo; F Baquero-Artigao; A Garcia-Perea
Journal:  Pediatr Infect Dis J       Date:  1998-02       Impact factor: 2.129

5.  Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany.

Authors:  R R Reinert; M van der Linden; I Seegmüller; A Al-Lahham; A Siedler; B Weissmann; A M Toschke; R von Kries
Journal:  Clin Microbiol Infect       Date:  2007-04       Impact factor: 8.067

6.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

7.  A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR.

Authors:  J Yu; M da G S Carvalho; B Beall; M H Nahm
Journal:  J Med Microbiol       Date:  2008-02       Impact factor: 2.472

8.  Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel.

Authors:  Nurith Porat; Uri Amit; Noga Givon-Lavi; Eugene Leibovitz; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2010-02       Impact factor: 2.129

9.  Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.

Authors:  Michael E Pichichero; Janet R Casey
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

10.  Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland.

Authors:  D Bennett; B Lennon; H Humphreys; M Cafferkey
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  5 in total

1.  Noninvasive pneumococcal clones associated with antimicrobial nonsusceptibility isolated from children in the era of conjugate vaccines.

Authors:  Martha McElligott; Imelda Vickers; Mary Meehan; Mary Cafferkey; Robert Cunney; Hilary Humphreys
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

2.  The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?

Authors:  M Corcoran; I Vickers; J Mereckiene; S Murchan; S Cotter; M Fitzgerald; M McElligott; M Cafferkey; D O'Flanagan; R Cunney; H Humphreys
Journal:  Epidemiol Infect       Date:  2017-08       Impact factor: 4.434

3.  Colonisation of Irish patients with chronic obstructive pulmonary disease by Streptococcus pneumoniae and analysis of the pneumococcal vaccine coverage: a non-interventional, observational, prospective cohort study.

Authors:  Hannah McCarthy; Mandy Jackson; Mary Corcoran; Martha McElligott; Elaine MacHale; Imran Sulaiman; Breda Cushen; Richard W Costello; Hilary Humpreys
Journal:  BMJ Open       Date:  2017-07-09       Impact factor: 2.692

Review 4.  Porous bead-based diagnostic platforms: bridging the gaps in healthcare.

Authors:  Jie Chou; Jorge Wong; Nicolaos Christodoulides; Pierre N Floriano; Ximena Sanchez; John McDevitt
Journal:  Sensors (Basel)       Date:  2012-11-09       Impact factor: 3.576

5.  A versatile PDMS/paper hybrid microfluidic platform for sensitive infectious disease diagnosis.

Authors:  Maowei Dou; Delfina C Dominguez; XiuJun Li; Juan Sanchez; Gabriel Scott
Journal:  Anal Chem       Date:  2014-07-24       Impact factor: 6.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.